about
Enhancing cellular uptake of activable cell-penetrating peptide-doxorubicin conjugate by enzymatic cleavage.Comparative studies of polyethylenimine-doxorubicin conjugates with pH-sensitive and pH-insensitive linkers.Chemotherapeutic drug delivery to cancer cells using a combination of folate targeting and tumor microenvironment-sensitive polypeptides.pH-responsive complexes using prefunctionalized polymers for synchronous delivery of doxorubicin and siRNA to cancer cells.A survey on "Trojan Horse" peptides: opportunities, issues and controlled entry to "Troy".Tumor-specific penetrating peptides-functionalized hyaluronic acid-d-α-tocopheryl succinate based nanoparticles for multi-task delivery to invasive cancers.Enhance Cancer Cell Recognition and Overcome Drug Resistance Using Hyaluronic Acid and α-Tocopheryl Succinate Based Multifunctional Nanoparticles.Targeting and microenvironment-responsive lipid nanocarrier for the enhancement of tumor cell recognition and therapeutic efficiency.Development and evaluation of liquid embolic agents based on liquid crystalline material of glyceryl monooleate.Tumor-targeting dual peptides-modified cationic liposomes for delivery of siRNA and docetaxel to gliomas.Pharmacokinetics, brain distribution, release and blood-brain barrier transport of Shunaoxin pills.PSA-responsive and PSMA-mediated multifunctional liposomes for targeted therapy of prostate cancer.Enhanced antitumor efficacy and decreased toxicity by self-associated docetaxel in phospholipid-based micelles.Magnetic targeting after femoral artery administration and biocompatibility assessment of superparamagnetic iron oxide nanoparticles.Sustained release of cisplatin from multivesicular liposomes: potentiation of antitumor efficacy against S180 murine carcinoma.Therapeutic potential of targeted multifunctional nanocomplex co-delivery of siRNA and low-dose doxorubicin in breast cancer.Cholesteryl hemisuccinate as a membrane stabilizer in dipalmitoylphosphatidylcholine liposomes containing saikosaponin-d.Superparamagnetic iron oxide nanoparticles stabilized by alginate: pharmacokinetics, tissue distribution, and applications in detecting liver cancers.Taming the Wildness of "Trojan-Horse" Peptides by Charge-Guided Masking and Protease-Triggered Demasking for the Controlled Delivery of Antitumor Agents.Delivering siRNA and Chemotherapeutic Molecules Across BBB and BTB for Intracranial Glioblastoma Therapy.Intelligent "Peptide-Gathering Mechanical Arm" Tames Wild "Trojan-Horse" Peptides for the Controlled Delivery of Cancer Nanotherapeutics.Roles of ligand and TPGS of micelles in regulating internalization, penetration and accumulation against sensitive or resistant tumor and therapy for multidrug resistant tumors.Development of a local vasodilator delivery system using fibrin glue to prevent arterial graft from spasm.Neuroprotective Effects of a Standardized Flavonoid Extract from Safflower against a Rotenone-Induced Rat Model of Parkinson's Disease.Pharmaceutical and immunological evaluation of a single-dose hepatitis B vaccine using PLGA microspheres.Preparation and characterization of superparamagnetic iron oxide nanoparticles stabilized by alginateRates of systemic degradation and reticuloendothelial system uptake of calcein in the dipalmitoylphosphatidylcholine liposomes with soybean-derived sterols in miceRemote loading of diclofenac, insulin and fluorescein isothiocyanate labeled insulin into liposomes by pH and acetate gradient methodsConstruction of Hyaluronic Tetrasaccharide Clusters Modified Polyamidoamine siRNA Delivery SystemPharmacokinetics and pharmacodynamics of sterylglucoside-modified liposomes for levonorgestrel delivery via nasal route
P50
Q34278720-7676A77B-6953-42F9-821F-36DFBD5E9264Q34445374-B9F62FDE-4A6D-4695-8A28-84A399F01923Q34604822-D83A601D-6735-43BD-9869-264469C0A181Q34642335-91E75003-1607-4316-9312-EDC5177E451FQ38242733-F71276BA-58F8-4A7C-9C14-699AFAD7A439Q38840575-5EBA9E64-4A1C-467F-90CB-D661689CCA83Q38878589-042EC862-FF57-43F7-A4C9-A55D1D57ED74Q38927345-8E5B03C2-2443-405A-A96A-0EDF18BF1043Q38991986-A3ADAE52-B0C2-4CE7-B28F-ECBA0E6AF0ACQ39008799-25EA7B36-0020-4E69-AC90-520A11D0D350Q39039018-D7B8AB21-2895-480D-BD6D-DB5BD43CC1B5Q39137904-F121B068-567E-4FB0-A90E-C58505320AA5Q39331319-CA9BCCCB-4966-452A-A82D-1734212E43DDQ40109773-EB1DC4C9-6A7C-4777-8045-1A470CEAAA0AQ40549514-9F948045-3E73-459F-A03F-ABEA8CD27D19Q45872052-FF7F0678-F5A1-46B5-9220-D68C3E9DCE2FQ46566860-63DE31A1-C986-48A8-B06A-5969F4B2EE53Q46811206-E00A74E9-878B-4483-B905-86B7F79D7AF0Q48131677-B5EAB568-153C-4D19-B35C-54F72D5098C9Q48171889-319EE2BB-387E-417A-994D-DCD852BFD7E4Q48262169-34659908-830E-41A3-8894-44CB0D0E09C5Q50987089-71EE8A09-F8E8-4B7A-8657-8F121551BEFEQ51075923-DF6C4A24-F3B7-448E-8E2B-21D422C7E809Q51184240-D6ED6104-47D8-4672-BB1F-70242D56D592Q51253137-BCF9AF86-F0A7-4A63-A8F6-B4105D76CA8DQ57187071-E4EE97A7-B7EA-40F0-B7DF-FCD621F12281Q72175768-49B323E4-2584-4362-B6FA-D4571909B403Q74533983-7044B34E-9EEE-451A-8E10-B20B405C3547Q89094217-6AD1BFDE-1B8A-4E65-A099-0A93A878035DQ94518525-6150CD0C-E060-4D50-9ED0-EA7E4DACE608
P50
description
researcher
@en
wetenschapper
@nl
name
X R Qi
@en
X R Qi
@nl
type
label
X R Qi
@en
X R Qi
@nl
prefLabel
X R Qi
@en
X R Qi
@nl
P106
P31
P496
0000-0002-8264-0794